The surgeon and the child with cancer: A report of the International Society of Pediatric Surgical Oncology (IPSO)

Medical and Pediatric Oncology

Volumn 34, Issue 6, 2000, Pages 424-428

  Rao, Bhaskar N ^a,f   Tsuchida, Yoshiaki ^b   Kaneko, Michio ^c   Spicer, Richard D ^d   Plaschkes, Jack ^e  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b Gumna Children S Medical Center   (Japan)

^c UNIVERSITY OF TSUKUBA   (Japan)

^d BRISTOL ROYAL HOSPITAL FOR CHILDREN   (United Kingdom)

^e UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^f FACS   (United States)

Author keywords

Malignant neoplasms; Oncology; Pediatric cancer; Surgical oncology

Indexed keywords

ABSCESS DRAINAGE; ACUTE ABDOMEN; ARTICLE; CANCER PREVENTION; COLON CANCER; DOCTOR PATIENT RELATION; GRAM NEGATIVE INFECTION; HUMAN; LIVER CANCER; MEDICAL DECISION MAKING; NEUROBLASTOMA; PERIANAL ABSCESS; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; THYROID MEDULLARY CARCINOMA; TREATMENT PLANNING;

CHILD; CHILD, PRESCHOOL; HUMANS; IMMUNOCOMPROMISED HOST; LIVER NEOPLASMS; NEOPLASMS; NEUROBLASTOMA; TIME FACTORS;

EID: 0034080447     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-911X(200006)34:6<424::AID-MPO8>3.0.CO;2-V     Document Type: Article

References (46)

1. De Bermardi B, Conte M, Mancini A, et al. Localized resectable neuroblastoma: results of the second study of the Italian Cooperative Group for Neuroblastoma. J Clin Oncol 1995;13:884-893.
2. Haase GM, Atkinson JB, Stram D, et al. Surgical management and outcome of locoregional neuroblastoma: comparison of the Childrens Cancer Group and the International staging systems. J Pediatr Surg 1995;30:289-294.
3. Rubie H, Hartmann O, Michon J, et al. N-myc gene amplification is a major factor in localized neuroblastoma: results of the French NBL 90 Study. Neuroblastoma Study Group of the Societe Francaise d'Oncologie Pediatrique. J Clin Oncol 1997;15:1171-1182.
4. Matsumura T, Michon J. Treatment of localized neuroblastoma. In: Brodeur GM, Sawada T, Tsuchida Y, et al., editors. Neuroblastoma. Amsterdam: Elsevier Science. In press.
5. Holgersen LO, Subramanian S, Kirpekar M, et al. Spontaneous resolution of antenatally diagnosed adrenal masses. J Pediatr Surg 1996;31:153-155.
6. Yamamoto H, Yoshida M, Sera Y. Laparoscopic surgery for neuroblastoma identified by mass screening. J Pediatr Surg 1996;31: 385-388.
7. Haase GM, Wong KY, deLorimier AA, et al. Improvement in survival after excision of primary tumor in stage III neuroblastoma. J Pediatr Surg 1989;24:194-200.
8. Tsuchida Y, Yokoyama J, Kaneko M, et al. Therapeutic significance of surgery in advanced neuroblastoma: a report from the Study Group of Japan. J Pediatr Surg 1992;27:616-622.
9. Matthay KK, Atkinson JB, Stram DO, et al. Patterns of relapse after autologous purged marrow transplantation for neuroblastoma: a Childrens Cancer Group pilot study. J Clin Oncol 1993; 11:2226-2233.
10. La Quaglia MP, Kushner BH, Heller G, et al. Stage 4 neuroblastoma diagnosed at more than 1 year of age: gross total resection and clinical outcome. J Pediatr Surg 1994;29:1162-1165.
11. Matsumura M, Atkinson JB, Hays DM, et al. An evaluation of the role of surgery in metastatic neuroblastoma. J Pediatr Surg 1988; 23:448-453.
12. Kiely EM. The surgical challenge of neuroblastoma. J Pediatr Surg 1994;29:128-133.
13. Kaneko M, Nishihira H, Mugishima H, et al. Stratification of treatment of stage 4 neuroblastoma patients based on N-myc amplification status. Study Group of Japan for Treatment of Advanced Neuroblastoma, Tokyo, Japan. Med Pediatr Oncol 1998;31:1-7.
14. Stram DO, Matthay KK, O'Leary M, et al. Consolidation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma: a report of two concurrent Children's Cancer Group studies. J Clin Oncol 1996;14:2417-2426.
15. Tsuchida Y, La Quaglia MP. Surgery for neuroblastoma. In: Brodeur GM, Sawada T, Tsuchida Y, et al., editors. Neuroblastoma. Amsterdam: Elsevier Science. In press.
16. Exelby PR, Filler RM, Grosfeld JL. Liver tumors in children in the particular reference to hepatoblastoma and hepatocellular carcinoma: American Academy of Pediatrics Surgical Section Survey - 1974. J Paediatr Surg 1975;10:329-337.
17. Clatworthy HW Jr, Boles ET Jr. Right lobectomy of the liver in children. Surgery 1956;39:850-859.
18. Tung TT, Quang ND. A new technique for operating on the liver. Lancet 1963;7271:192-193.
19. Couinaud C. La foie: études anatomiques et chirurgicales. Paris: Masson & Cie: 1957.
20. Howat JM. Major hepatic resection in infancy and childhood. Gut 1971;12:212-217.
21. Wheatly JM, LaQuaglia MP. Management of hepatic epithelial malignancy in childhood and adolescence. Semin Surg Oncol 1993;9:532-540.
22. Rao BN, Green AA. Hepatic tumors in children and adolescents. In: Wanebo HJ, editor. Hepatic and biliary cancer. New York: Marcel Dekker; 1986. p 187-218.
23. Douglass EC, Green AA, Wrenn E, et al. Effective cisplatin (DDP) based chemotherapy in the treatment of hepatoblastoma. Med Pediatr Oncol 1985;13:187-190.
24. Black CT, Cangir M, Choroszy M, et al. Marked response to preoperative high-dose cis-platinum in children with unresectable hepatoblastoma. J Pediatr Surg 1991;26:1070-1073.
25. Ninane J, Perilongo G, Stalens JP, et al. Effectiveness and toxicity of cisplatin and doxorubicin (PLADO) in childhood hepatoblastoma and hepatocellular carcinoma: a SIOP pilot study. Med Pediatr Oncol 1991;19:199-203.
26. Ortega JA, Krailo MD, Haas JE, et al. Effective treatment of unresectable or metastatic hepatoblastoma with cisplatin and continuous infusion doxorubicin chemotherapy: a report from the Childrens Cancer Study Group. J Clin Oncol 1991;9:2167-2276.
27. Filler RM, Tefft M, Vawter F, et al. Hepatic lobectomy in childhood: effects of x-ray and chemotherapy. J Pediatr Surg 1969;4:31-41.
28. Evans AE, Land VJ, Newton WA, et al. Combination chemotherapy (vincristine, adriamycin, cyclophosphamide, and 5 fluorouracil) in the treatment of children with malignant hepatoma. Cancer 1982;50:821-826.
29. Quinn JJ, Altman AJ, Robinson HT, et al. Adriamycin and cisplatin for hepatoblastoma. Cancer 1985;56:1926-1929.
30. Douglass EC, Reynolds M, Finegold M, et al. Cisplatin, vincristine, and fluorouracil therapy for hepatoblastoma: a Pediatric Oncology Group study. J Clin Oncol 1993;11:96-99.
31. Ortega JA, Douglass E, Feusner J, et al. A randomized trial of cisplatin (DDP), vincristine (VCR), 5-fluorouracil (5FU) vs DDP/ doxorubicin (DOX) iv continuous infusion (CI) for the treatment of hepatoblastoma (HB): results from the Pediatric Intergroup Hepatoma Study (CCG-8881/POG-8945) [abstract]. Proc Annu Meet Am Soc Clin Oncol 1994;13:A142I.
32. Perilongo G, Plaschkes J, Zimmerman A. Liver tumours in children. In: Souhami R, editor. Oxford textbook of oncology. London: Oxford University Press. In press.
33. von Schweinitz D, Wischmeyer P, Leuschner I, et al. Clinical pathological criteria with prognostic relevance in hepatoblastoma. Eur J Cancer 1994;30A:1052-1058.
34. Gauthier F, Saliou CH, Valayer J, et al. Surgery of hepatoblastoma and hepatocarcinoma in children in the era of preoperative chemotherapy. Current progress and limitations [in French]. Chir Pediatr 1988;29:307-312.
35. Koneru B, Flue MW, Busuttil RW, et al. Liver transplantation for hepatoblastoma. The American experience. Ann Surg 1991;213: 118-121.
36. Cosimi AB. Surgical aspects of infection in the compromised host. In: Rubin RH, Young LS, editors. Clinical approach to infection in the compromised host, 3rd ed. New York: Plenum Medical Book Company; 1994. p 707-729.
37. Ettinghausen SK. Collagenous colitis, eosinophilic colitis, and neutropenic colitis. Surg Clin North Am 1993;73:993-1016.
38. Armitage JO. Bone marrow transplantation. N Engl J Med 1994; 330:827-838.
39. Angel C, Patrick CC, Lobe T, et al. Management of anorectal/ perineal infections caused by Pseudomonas aeruginosa in children with malignant diseases. J Pediatr Surg 1991;26:487-492.
40. Fergie JE, Patrick CC, Lott L. Pseudomonas aeruginosa cellulitis and ecthyma gangrenosum in immunocompromised children. Pediatr Infect Dis J 1991;10:496-500.
41. Sencer SF, Haake RJ, Weisdorf DJ. Hemorrhagic cystitis after bone marrow transplantation. Risk factors and complications. Transplantation 1993;56:875-879.
42. Wells SA Jr, Chi DD, Toshima K, et al. Predictive DNA testing and prophylactic thyroidectomy in patients at risk for multiple endocrine neoplasia type 2A. Ann Surg 1994;220:237-250.
43. Burt RW. Hereditary aspects of the polyposis syndromes. Hematol Oncol Ann 1994;2:163-170.
44. Rozanski TA, Bloom DA. Male genital tract. In: Oldham KT, Colombani PM, Foglia RP, editors. Surgery of infants and children. Scientific principles and practice. Philadelphia: Lippincott-Raven Publishers; 1997. p 1543-1558.
45. Riccardi VM. Management. In: Riccardi VM, Eichner JE, editors. Neurofibromatosis: phenotype, natural history, and pathogenesis. Baltimore: Johns Hopkins University Press; 1986. p 227-233.
46. Pappo AS, Kaste S, Rao BN, Pratt CB. Childhood melanoma. In: Balch CM, Sober AJ, Houghton AN, et al., editors. Cutaneous melanoma, 3rd ed. St. Louis: Quality Medical Publishing; 1998. p 176-180.